179 related articles for article (PubMed ID: 24374995)
21. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
22. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
[TBL] [Abstract][Full Text] [Related]
23. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke.
Arnarsdottir L; Hjalmarsson C; Bokemark L; Andersson B
BMC Neurol; 2012 Aug; 12():67. PubMed ID: 22866821
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
26. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
27. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China.
Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L;
Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269
[TBL] [Abstract][Full Text] [Related]
28. Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.
Barlas RS; Loke YK; Mamas MA; Bettencourt-Silva JH; Ford I; Clark AB; Bowles KM; Metcalf AK; Potter JF; Myint PK
Am J Cardiol; 2018 Sep; 122(6):1085-1090. PubMed ID: 30072125
[TBL] [Abstract][Full Text] [Related]
29. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
[TBL] [Abstract][Full Text] [Related]
30. Clinical features, management and outcomes of severe ischaemic stroke in tertiary hospitals in China: protocol for a prospective multicentre registry-based observational study.
Wu S; Yuan R; Xiong Y; Zhang S; Wu B; Liu M
BMJ Open; 2018 Oct; 8(10):e024900. PubMed ID: 30373783
[TBL] [Abstract][Full Text] [Related]
31. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
Deguchi I; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321
[TBL] [Abstract][Full Text] [Related]
32. Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Dourliou V; Sofogianni A; Savopoulos C; Hatzitolios AI
J Thromb Thrombolysis; 2016 Feb; 41(2):336-42. PubMed ID: 26253707
[TBL] [Abstract][Full Text] [Related]
33. Ischemic stroke in patients receiving aspirin.
Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
[TBL] [Abstract][Full Text] [Related]
34. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
[TBL] [Abstract][Full Text] [Related]
35. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulants for acute ischaemic stroke.
Sandercock PA; Counsell C; Kamal AK
Cochrane Database Syst Rev; 2008 Oct; (4):CD000024. PubMed ID: 18843603
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulants versus antiplatelet agents for acute ischaemic stroke.
Berge E; Sandercock P
Cochrane Database Syst Rev; 2002; (4):CD003242. PubMed ID: 12519590
[TBL] [Abstract][Full Text] [Related]
38. Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation.
Hellwig S; Grittner U; Audebert H; Endres M; Haeusler KG
Europace; 2018 Apr; 20(4):569-574. PubMed ID: 28460024
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy for Patients with Atrial Fibrillation and Cerebral Microbleeds.
Badi MK; Vilanilam GK; Gupta V; Barrett KM; Lesser ER; Cochuyt JJ; Hodge DO; Brott TG; Meschia JF
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2159-2167. PubMed ID: 31103554
[TBL] [Abstract][Full Text] [Related]
40. Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.
Shrestha S; Coy S; Bekelis K
Curr Pharm Des; 2017; 23(9):1377-1391. PubMed ID: 28003013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
